CELH— AI Stock Forecast & Price Targets

Published 7/24/2026 · A free sample of K3vl4r’s AI-powered analysis.

Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.

View the live CELH price forecast →

CELH has broken down to a fresh 52-week low at $27.17, testing the very support level that prior calls flagged as invalidation. Operationally the story remains intact (Q1 revenue +138% YoY to $783M via Alani Nu/Rockstar into Pepsi DSD), but a 65x trailing P/E, gross margin compression to 48.3%, 20% short float, and an Aug 10 earnings binary keep this a HOLD — the risk/reward is not compelling enough to add pre-print, nor washed-out enough to sell into a potential squeeze.

HOLD
medium convictiongenerated 7/24/2026, 7:44:56 AM
Scores
Fundamentals
6.0
Technicals
3.0
Growth potential
7.0
Risk
7.5
Overall
5.3
Charts the model saw
Bear
$22.00
Base
$30.00
Bull
$38.00
over ~6 months
Investment plan
Short term · 1-4 weeks

HOLD/no new exposure into the Aug 10 print. Price at $27.17 is right on 52-week low ($27.07); a decisive break below $27 opens $24-25 quickly. Key levels: reclaim $28.50 = short-term neutral, reclaim $30 = trend repair begins; break $27 = trapdoor to $24. With 20% short float and RSI 36.8, an oversold squeeze on any decent print is possible, but earnings is a binary — do NOT add pre-print. Stance into earnings: neutral, sized-small if already long. Invalidation for any long: close below $26.50 on volume.

Mid term · 1-6 months

The 6-month view hinges entirely on whether Q2 confirms (a) revenue holding $780M+ run-rate, (b) gross margin stabilizing at/above 48%, and (c) organic CELSIUS core brand reaccelerating above 6%. If yes, forward P/E 13.7x on $1.98 EPS supports a re-rate toward $32-35. If margins compress further or organic slows, the stock re-tests $22-24 as the market questions the forward EPS. Expected return range: −15% to +25% over 6 months, skewed slightly negative given the calibration record of prior optimistic targets on this name (0/8 recent calls were directionally right).

Long term · 1-3 years

1-3 year terminal thesis: CELH is a bet on becoming the #3 US energy drink platform behind Monster and Red Bull via the Pepsi DSD moat, with Alani Nu capturing the female/functional wellness segment and international expansion (Suntory Asia, Europe) as an optional call. If management executes to the SimplyWallSt narrative of $4B revenue / $606M earnings by 2029 (10.4% revenue CAGR), fair value is $45-55 on a 20x forward multiple. Biggest structural risk: the energy drink category is showing signs of maturation, Monster/Coke can respond aggressively on price and shelf, and Pepsi DSD concentration is a single point of failure. Secondary risk: regulatory scrutiny on marketing to youth (Texas AG-type probes).

Fundamentals

Top-line is exceptional: Q1 2026 revenue of $782.6M (+138% YoY) with TTM revenue at $2.97B, driven by Alani Nu/Rockstar integration into Pepsi's DSD network. However, quality of growth is deteriorating on key axes — gross margin compressed from 51.5% (Q2'25) to 48.3% (Q1'26), and TTM ROE is only 8.1% / ROIC 4.7% despite the topline surge, indicating the acquisitions were dilutive to returns on capital. Balance sheet is solid on absolute terms ($549M cash, $676M debt, current ratio 1.77) but debt/equity of 1.95 reflects the leveraged Alani Nu deal, and the July 15 8-K refinancing signals ongoing rate management. Cash flow is lumpy — Q4'25 OCF was −$119M before rebounding to +$74M in Q1'26; the TTM $330M OCF number masks this volatility. Valuation is the crux: trailing P/E 64.9x is punitive, but forward P/E 13.7x and PEG 0.74 are attractive IF forward EPS of $1.98 materializes. That's a big 'if' given margin trajectory.

Technicals

The tape is broken across all three timeframes shown. On the 1h, price has ground down from $34 (early July) to $27.25, punching through the $28.50 support flagged in prior notes. The 4h shows a clean six-month downtrend from $55 to a fresh low, with price sitting at the 52-week low of $27.07 (only 0.4% off the floor) and 59.3% below the 52-week high — a full bear-market drawdown. The daily/weekly shows this is the third leg down of a year-long distribution from $95. RSI 36.8 is oversold but not extreme; SMA20 −9.6%, SMA50 −8.7%, SMA200 −35.2% — all timeframes bearish. The model's yellow forecast bands ($30.5 short-term, $40.8 medium-term, $47 long-term) look wildly optimistic given realized 1d directional accuracy of 22% vs 79% naive baseline — the model is materially worse than a coin flip on this name and should be discounted. Only bullish tell: price is deeply oversold into a 20% short float going into earnings, setting up squeeze fuel IF the print delivers.

News read

Signal: Q1 2026 confirmed operational reacceleration (EPS $0.41 beat $0.29, revenue +138% YoY), management guided to Q2 retail resets delivering ~17% space gain for CELSIUS and >100% for Alani Nu, and a July 15 8-K disclosed refinancing of existing loans with adjusted interest rates. Q2 earnings are confirmed for Aug 6-10 window — the key binary. Recent Trefis/TIKR pieces flag that the stock is at a technical floor that has produced seven prior rallies, but also that Alani Nu is 'carrying' the business while the core CELSIUS brand slowed to 6% growth — a legitimate concern about organic momentum. Noise: Motley Fool 'Best Stocks to Buy' pieces and the 10-year total-return framing are backward-looking. Social sentiment is 100% bullish among tagged messages, which in a stock making fresh 52-week lows is a contrarian yellow flag (retail bag-holding). The Bloomberg TV mention was unrelated (physics context).

Growth / roadmap
  • Q2 2026 retail reset delivering ~17% shelf gain for CELSIUS and >100% for Alani Nu (management guidance)
  • Alani Nu contribution ($332M Q1 sales, 55% of category growth) with full-year DSD synergies still ramping
  • International expansion via Suntory (Asia) and European rollout — currently untapped in TTM numbers
  • Refinancing completed July 15 8-K lowers interest expense drag on forward EPS
  • Consensus forward EPS $1.98 implies ~4.7x earnings growth from TTM $0.42 — the setup for multiple re-rate IF delivered
Risks
  • Aug 10 earnings binary — any miss on gross margin (48.3% floor) or revenue (<$780M) opens a gap toward $22-24
  • Trailing P/E 64.9x offers zero cushion; forward P/E 13.7x depends on EPS more than 4x current TTM
  • Core CELSIUS brand organic growth slowed to 6% — Alani Nu masking softness in the flagship
  • 20% short float and 19% YTD retail sentiment bullishness create asymmetric squeeze/capitulation risk
  • Gross margin compression from 51.5% to 48.3% may be structural (mix dilution from Rockstar/Alani) not transient
  • Debt/equity 1.95, refinancing activity suggests ongoing balance sheet management pressure
  • Model forecast reliability is poor on this name (22% directional accuracy vs 79% naive) — do not anchor to the $30-47 model bands
  • Prior calls on this name have run 22% optimistic on base targets — calibration says discount upside

Get AI analysis on any stock

This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.